Amitriptyline for Phantom-limb Pain Prevention

Authors

  • Flavia Claro da Silva Médica Anestesiologista, Responsável pelo Serviço de Terapia Analgésica Oncológica do Instituto Nacional de Câncer (INCA), RJ https://orcid.org/0009-0001-1885-3963
  • Fabíola Caó de Barros Moreno Coordenadora da Pós-Graduação em Terapia Analgésica Oncológica do INCA. Pós-Graduação em Geriatria, Médica Staff do Serviço de Dor Crônica do INCA, RJ https://orcid.org/0009-0001-1885-3963
  • Paulo Francisco Mascarenhas Bender Médico Anestesiologista do INCA, RJ https://orcid.org/0009-0001-1885-3963
  • Carmen Dulce Barros de Carvalho Médica nefrologista, Acupunturista do HEMORIO - RJ. Pós-Graduação em Terapia Analgésica Oncológica no INCA, RJ https://orcid.org/0009-0001-1885-3963

DOI:

https://doi.org/10.32635/2176-9745.RBC.2008v54n4.1688

Keywords:

Pain, Phantom limb, Antidepressive agents, tricyclic

Abstract

Phantom-limb pain is a common sequela of amputation. Its etiology is not well known yet. Central changes seem to be a major determinant of phantom-limb pain, however peripheral and psychological factors may contribute to it. Among all of pharmacological interventions, tricyclic antidepressants seem to be one of the treatments of choice, although there have been no controlled studies of these agents for the approach of phantom-limb pain. Besides, tricyclic antidepressants are worldwide used in the treatment of a great variety of pain syndromes, especially those which have neurophatic aspects. The purpose of this opinion article is to propose the use of the tricyclic antidepressants to the prevention of the phantom-limb pain phenomena.

Downloads

Download data is not yet available.

Published

2008-12-31

How to Cite

1.
Silva FC da, Moreno FC de B, Bender PFM, Carvalho CDB de. Amitriptyline for Phantom-limb Pain Prevention. Rev. Bras. Cancerol. [Internet]. 2008 Dec. 31 [cited 2024 Nov. 22];54(4):345-9. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/1688

Most read articles by the same author(s)